Mr William J. Kridel, Jr., JD, Managing Director, Ferghana Partners
Group
2
What does the future hold for stem cell research and therapies?
Dr. Samuel J.K Abraham, Director, Nichi-In Centre for Regenerative
Medicine (NCRM), India , Dept of Surgery,Yamanashi University-Faculty of
Medicine, Japan
Dr Dirk Büscher, Vice President of Research, Cellerix, Spain
Mr William J. Kridel, Jr., JD, Managing Director, Ferghana Partners
Group, USA
3
How can nanotechnology revolutionise the delivery of healthcare
services through its various applications?
Professor John F. Ryan, Director, Bionanotechnology IRC, Director
Institute of Nanoscience for Medicine, University of Oxford, UK
Dr. Andreas Jordan, CEO, MagForce Nanotechnologies AG,
Germany
Prof Soodursun Jugessur, Pro-Chancellor, University of Mauritius
and Chairman, Mauritius Research Council
4
Success stories and best practices in medical and dental travel
Mr Keith Pollard, CEO, Treatment Abroad, UK
Mr Rudy Rupak, President and Co-founder, Planet Hospital, USA
Dr Narottam Puri, President of Medical Strategy, Fortis Healthcare,
India
5
Case Study: Investing in the healthcare sector in Mauritius
Dr Ed L. Hansen, CEO, Apollo Bramwell Hospital
Dr Narottam Puri, President of Medical Strategy, Fortis Healthcare,
India
Mr Tony Lingiah, CEO, Clinique Pierre Janet
6
Latest trends in geriatrics and rehabilitative medicine. How can
Mauritius position itself as a destination for geriatrics and rehabilitative
medicine?
Mr Jon Gooding, CEO, Retirement Villages Ltd, UK
Mr Rudy Rupak, President and Co-founder, Planet Hospital, USA
7
Cross border investment in healthcare and life sciences. What are
the different models?
Mr Michael Flemming, Managing Director, Life Healthcare Group,
South Africa
Mr Thumbay Moideen, President Gulf Medical Group, UAE
Prof Anupam Sibal, Group Medical Director, Apollo Hospitals, India
8
How can Biotechnology provide soultions to the healthcare industry?
Dr Rashmi Barbhaiya, CEO and MD, Advinus Therapuetics, India
Dr Dirk Buscher, Vice President of Research, Cellerix, Spain
9
Paving the way from bioinformatics to genomics and proteomics. What
are the challenges facing this industry? What are the opportunities for
Mauritius?
Dr Mohammad M Afshar, CEO, Ariana Pharma
Dr R. S. Nadig, President Operations & Deputy Dean, CREMA,
India
10
Challenges and Opportunities for CROs
Dr Michel Levy, President, Advanced Drug Development Services SAS,
France
Dr R. S. Nadig, President Operations & Deputy Dean, CREMA,
India
Session Chair: Dr N. Gopee, Director General Healthcare
Services, Ministry of Health and Quality of Life
11
Pre-clinical research: What are the key success factors?
Professor C. Thiemermann, CEO, William Harvey Research Limited, UK
Dr Rashmi H. Barbhaiya, CEO and MD, Advinus Therapeutics Pvt Ltd,
India
